Trexquant Investment LP Alpine Immune Sciences, Inc. Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$17.75 - $41.6 $1.1 Million - $2.58 Million	61,996 Added 115.28%	115,776 $4.59 Million
Q4 2023 Feb 09, 2024	BUY	$8.54 - $20.22 $215,225 - $509,584	25,202 Added 88.19%	53,780 $1.03 Million
Q3 2023 Nov 13, 2023	SELL	$10.13 - $13.98 $143,795 - $198,446	-14,195 Reduced 33.19%	28,578 $327,000
Q2 2023 Aug 11, 2023	BUY	$6.84 - $11.91 $292,567 - $509,426	42,773 New	42,773 $439,000
Q4 2022 Feb 13, 2023	BUY	$5.45 - $7.35 $32,901 - $44,371	6,037 Added 56.28%	16,763 $123,000
Q3 2022 Nov 14, 2022	BUY	$6.89 - $9.39 $73,902 - $100,717	10,726 New	10,726 $77,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.